VP
VERTEX PHARMACEUTICALS INC
VRTX· Health Care· BiotechnologyS&P 500
Close · 26/10/2026
517.49
1D
-1.23%52-week range
403.16 – 560.25
Volume
11,89,000.00
Price history
VRTX
25/09/2026 to 26/10/2026
O 526.86 H 529.66 L 509.33
1W+3.10%
1M-1.65%
3M+5.53%
6M+21.47%
1Y+22.45%
3Y+41.86%
5Y+186.22%
MAX+160.83%
Fundamentals
as of 26/10/2026- Market cap
- $131.16B
- Shares out
- 253.46M
- P/E (trailing)
- 29.77
- P/E (forward)
- 25.66
- EPS (trailing)
- 17.38
- Dividend yield
- 0.00%
- Beta
- 0.28
- Profit margin
- 35.00%
- P/B
- 6.48
- Return on equity
- 21.76%
SEC financial statements
65 quarterly and 18 annual periods through 30/06/2026.
Details
- Ticker
- VRTX
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 26/10/2026.
Tracked by Congress
10 filers · 1 on watchlist · 7 buys · 11 sells · ?: 2 · D: 2 · R: 14
- 26/08/2026David J. TaylorSellVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 03/05/2024Thomas H TubervilleWSellVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 27/03/2026Alan ArmstrongBuyVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 29/01/2026David J. TaylorSellVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 23/10/2024Julia LetlowBuyVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 07/08/2025David J. TaylorBuyVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 11/06/2025Lisa McClainSellVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 10/06/2025Lisa McClainSell+Vertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000